David Gonzalez Angulo
Net Worth

Last updated:

What is David Gonzalez Angulo net worth?

The estimated net worth of Mr. David Gonzalez Angulo is at least $7,115,208 as of 21 Dec 2020. He owns shares worth $18,608 as insider and has received compensation worth at least $7,096,600 in SCYNEXIS, Inc..

What is the salary of David Gonzalez Angulo?

Mr. David Gonzalez Angulo salary is $709,660 per year as Chief Medical Officer in SCYNEXIS, Inc..

How old is David Gonzalez Angulo?

Mr. David Gonzalez Angulo is 60 years old, born in 1965.

What stocks does David Gonzalez Angulo currently own?

As insider, Mr. David Gonzalez Angulo owns shares in one company:

Company Title Shares Price per share Total value
SCYNEXIS, Inc. (SCYX) Chief Medical Officer 23,780 $0.78 $18,608

What does SCYNEXIS, Inc. do?

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYX logo
SCYX
SCYNEXIS, Inc.
$0.78

David Gonzalez Angulo insider trading

SCYNEXIS, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 1,600 N/A N/A
Purchase
Common stock 12,000 N/A N/A
Purchase
Common Stock 7,000 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Purchase
Common Stock 21,790 N/A N/A
Purchase
Common Stock Warrant (right to buy) 17,747 $0.93 $16,416
Purchase
Common Stock Warrant (right to buy) 17,747 N/A N/A
Purchase
Common Stock 21,790 $1.54 $33,557
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 32,150 N/A N/A
Purchase
Common Stock 4,800 N/A N/A
Purchase
Common Stock 3,000 N/A N/A

SCYNEXIS key executives

SCYNEXIS, Inc. executives and other stock owners filed with the SEC: